GlobeStar Therapeutics Corp: auditor change — GlobeStar Therapeutics dismisses auditor M&K, engages Fruci & Associates; prior reports had going concern note

GlobeStar Therapeutics Corp

Effective June 20, 2023, board approved dismissal of M&K CPAS, PLLC and engagement of Fruci & Associates II, PLLC as auditor for FY ending Sept 30, 2023.
No disagreements or reportable events in fiscal years 2021-2022 or interim period; M&K's reports contained a going concern explanatory paragraph.
Company provided M&K with a copy of the disclosures and requested a letter; M&K's letter dated June 27, 2023 is filed as Exhibit 16.1.
No prior consultations with Fruci & Associates on accounting principles or audit opinion.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GlobeStar Therapeutics Corp dismissed M&K CPAS, PLLC as its auditor.

Action: dismissal
Auditor: M&K CPAS, PLLC
Successor: Fruci & Associates II, PLLC

Exact text from the filing

, and dismissed M&K CPAS, PLLC (“M&K”) as the Company’s independent registered public accounting firm.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

GlobeStar Therapeutics Corp engaged Fruci & Associates II, PLLC as its auditor.

Action: engagement
Auditor: Fruci & Associates II, PLLC

Exact text from the filing

approved the engagement of Fruci & Associates II, PLLC (“F&A”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending September 30, 2023, effective immediately

View on SEC.gov

Browse all auditor changes →

Source: SEC EDGAR

accession 0001161697-23-000380

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.